On the cash position and going concern, you have to understand that the 10K reports the outlook as of December 31, 2014.
The company raised $5.8 million in cash in March 2015. That's why the shares are down so much.
Around 25M shares were sold to fund the raise.
I think they now have enough cash to fund operations into the Q4.
The plan between now and then is to continue to develop LymPro and get eltoprazine into Phase 2b!
They desperately need some sort of clinical catalyst. Hopefully they have one very soon per Napadano.
When you click on friends and look at the friends and their occupation, many of the friends list their employment as Pot Farm...I am thinking that they are employees and friends.
Obamacare changed the rules...If the capital gains are over $300,000, the percent is 30% and does not matter if it is short term or long term.
Sentiment: Strong Buy